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GLUTAMINE SUPPLEMENTATION IN RECOVERY FROM
ECCENTRIC EXERCISE ATTENUATES
STRENGTH LOSS AND MUSCLE SORENESS
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The purpose of this study was to examine the effect of glutamine supplementation on indices of recovery 
following eccentric exercise. In a randomized single-blind placebo-controlled design, 15 physically active
males (mean age, 21 ± 1.5 years; mean height, 1.81 ± 0.07 m; mean body mass, 78.4 ± 9.2 kg) were assigned
to a control or glutamine intervention group. Each participant performed 100 drop jumps from 0.6 m fol-
lowed by ingestion of 0.3 g  kg−1 body mass of maltodextrin mixed with 750 mL of distilled water and lemon
flavoring (Control) or with an additional 0.3 g  kg−1 L-glutamine (Glutamine) at 0, 24, 48, and 72 hours post-
exercise. Knee-extensor concentric peak torque at angular velocities of 0.52 and 3.14 rad  s−1, perceived muscle
soreness, and plasma creatine kinase activity were measured at 0, 1, 24, 48, 72, and 96 hours post-exercise.
L-glutamine supplementation resulted in a greater preservation of peak torque over the 96-hour measure-
ment period at both 0.52 rad  s−1 (Control, 75 ± 16%; Glutamine, 85 ± 15% of pre-exercise values, p = 0.03)
and 3.14 rad  s−1 (Control, 79 ± 16%; Glutamine, 90 ± 12%, p = 0.01). Muscle soreness was significantly lower
over 96 hours with L-glutamine supplementation (Control, 4.6 ± 2.5 units; Glutamine, 3.6 ± 2.5 units, p =
0.03). L-glutamine supplementation did not affect the magnitude or temporal nature of the creatine kinase
response. As a therapeutic intervention, glutamine supplementation was effective in attenuating strength loss
and muscle soreness following eccentric exercise-induced muscle damage. [ J Exerc Sci Fit • Vol 9 • No 2 •
116–122 • 2011]
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Introduction
Exercise-induced muscle damage is associated with
impaired muscle function, delayed-onset muscle sore-
ness, and increased levels of muscle proteins in the
circulation (Byrne et al. 2004; Clarkson & Hubal 2002;
Warren et al. 1999). Symptoms of muscle damage are
most pronounced and recovery is longest when exercise
is unaccustomed and high-force eccentric muscle actions
are involved (e.g., resistance exercise, plyometrics,
downhill running), but is also evident after prolonged
low-force stretch-shortening cycle exercise such as 
distance running (Chambers et al. 1998; Nicol et al.
1996; Eston et al. 1995; Gibala et al. 1995; Golden &
Dudley 1992; Warhol et al. 1985; Sherman et al. 1984).
Prophylactic and therapeutic nutritional interventions
involving protein, protein hydrolysate, mixed amino
acids, selective amino acids, and branched-chain amino
acids have been demonstrated to be effective in reduc-
ing some or all of the symptoms of muscle damage fol-
lowing isolated eccentric muscle actions (Buckley et al.
2010; Jackman et al. 2010; Nosaka et al. 2006; Sugita
et al. 2003), resistance exercise (Kraemer et al. 2006),
downhill running (Etheridge et al. 2008), and endurance
exercise (Greer et al. 2007; Saunders et al. 2004;
Coombes & McNaughton 2000). Reductions in sore-
ness (Jackman et al. 2010; Greer et al. 2007; Nosaka 
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et al. 2006), strength loss (Buckley et al. 2010; Etheridge
et al. 2008; Greer et al. 2007; Kraemer et al. 2006;
Sugita et al. 2003), and blood markers such as creatine
kinase (CK) (Greer et al. 2007; Kraemer et al. 2006;
Nosaka et al. 2006; Saunders et al. 2004; Coombes &
McNaughton 2000) have been observed. The mecha-
nism(s) by which protein or amino acid supplementa-
tion attenuates symptoms of muscle damage are unclear.
Greater amino acid availability (Jackman et al. 2010;
Nosaka et al. 2006), extra energy intake from supple-
mentation (Jackman et al. 2010), increased protein
synthesis and/or decreased protein breakdown pro-
ducing a positive net protein balance (Etheridge et al.
2008; Kramer et al. 2006) have been suggested as
potential underlying mechanisms.
A potential therapeutic nutritional supplement that
has yet to be investigated following exercise-induced
muscle damage is the non-essential amino acid gluta-
mine. Glutamine is the most abundant amino acid in
human muscle and plasma, fulfilling numerous cell
regulatory roles and acts as a fuel source for intestinal
cells and leukocytes (Roth 2008; Wernerman 2008;
Castell 2003; Walsh et al. 1998). In critical illness, endo-
genous production of glutamine from skeletal muscle
becomes insufficient, resulting in depletion of gluta-
mine in muscle and plasma, which serve as reliable
prognostic markers (Roth 2008; Wernerman 2008).
Glutamine supplementation in clinical contexts has
been demonstrated to restore plasma glutamine and
improve net protein balance and immune system
function (Roth 2008; Wernerman 2008; Castell 2003).
In healthy individuals following very prolonged
exercise (i.e., > 2 hours), the plasma concentration of
glutamine has been demonstrated to decrease signifi-
cantly, by as much as 20–30% (Castell 2003; Walsh et al.
1998). Evidence documenting the influence of eccen-
tric exercise-induced muscle damage on plasma gluta-
mine concentration is equivocal (Gleeson et al. 1998;
Miles et al. 1990). In the 9 days of monitoring after
eccentric exercise, Miles et al. (1990) observed a sig-
nificant 24% reduction in plasma glutamine from
437μmol  L−1 pre-exercise to 332μmol  L−1 at day 3 post-
maximal eccentric exercise of the elbow and knee
flexors and extensors. Conversely, Gleeson et al. (1998)
observed no change in plasma glutamine for up to 10
days following 20 electrically stimulated submaximal
(≈40% isometric maximal voluntary contraction) eccen-
tric actions of the knee extensors. The discrepancy in
the above two studies may relate to the greater muscle
activation, force, and number of eccentric muscle 
actions in the study of Miles et al. (1990). Recent 
evidence has demonstrated an acute reduction in mus-
cle glutamine concentration following resistance exer-
cise (Blomstrand & Essen-Gustavsson 2009). Two hours
following 40 leg-press repetitions at 80% of one repe-
tition maximum, Blomstrand and Essen-Gustavsson
(2009) observed significant reductions in vastus later-
alis muscle glutamine concentrations of 34% and 29%
in type I and II fibers, respectively.
Therefore, potential exists for glutamine homeostasis
to be disturbed following eccentric exercise, manifested
as a reduction in muscle and/or plasma glutamine 
concentration (Blomstrand & Essen-Gustavsson 2009;
Miles et al. 1990). In such a context, oral glutamine
supplementation may restore glutamine homeostasis
and maintain a positive net protein balance and/or
reduce the inflammatory response to eccentric exer-
cise resulting in attenuation of exercise-induced mus-
cle damage and indirect markers such as strength loss,
soreness, and CK activity. Plasma glutamine can be ele-
vated acutely with oral glutamine ingestion (Castell &
Newsholme 1997; Ziegler et al. 1990). For example, an
oral dose of 0.1 g  kg−1 body mass (i.e., ≈7 g) results in
a 50% increase in plasma glutamine by 30 minutes,
followed by a return to baseline values in 1–2 hours
(Castell & Newsholme 1997). Clinical intravenous doses
of glutamine are typically 20–25 g per day (Wernerman
2008), and exercise studies have employed oral inges-
tion doses of up to 45 g per day for 6 weeks without
adverse effects (Gleeson 2008; Candow et al. 2001).
Therefore, the aim of this study was to evaluate 
the efficacy of oral glutamine supplementation as a
therapeutic nutritional intervention in an experimental
model of eccentric exercise-induced muscle damage.
We hypothesize that daily glutamine supplementation
post-eccentric exercise will reduce muscle damage and
attenuate the associated symptoms (i.e., strength loss,
soreness, and CK activity), thereby improving recovery
from this form of exercise.
Methods
Participants
Fifteen physically active males volunteered with in-
formed consent to participate in this study, which had
been approved by the ethics committee of the School of
Sport and Health Sciences at the University of Exeter.
Volunteers were free from musculoskeletal injury and
had not taken any dietary supplement within the past
6 months. Volunteers were randomly assigned in a single-
blind manner to a control group (n = 8) or glutamine
intervention group (n = 7). The Table illustrates the 
volunteers’ physical characteristics. Volunteers had an
equivalent body mass, but the stature of the control group
was greater than that of the glutamine group. Volunteers
were instructed to avoid therapeutic treatment of any
symptoms of muscle damage and to maintain their
normal diet throughout the experiment.
Experimental design
One week prior to the first experimental trial, volunteers
attended a familiarization session whereby demon-
strations of the testing procedures were provided with
volunteers undertaking no eccentric exercise. The exper-
imental design consisted of baseline testing followed
by repeated testing of the same parameters at 1, 24, 48,
72, and 96 hours following muscle-damaging exercise.
Baseline values of plasma CK activity, muscle sore-
ness, and knee extensor peak torque were established.
Volunteers then immediately performed 100 drop jumps
(10 sets, 10 reps, 1-minute recovery) from a height of
0.6 m (Highton et al. 2009). They were instructed to
achieve 90° of knee flexion followed by a jump for
maximum height. Volunteers received verbal encour-
agement throughout the protocol to maintain maximal
effort.
L-glutamine supplementation
Immediately following the muscle damage protocol,
volunteers ingested 0.3 g  kg−1 body mass of maltodex-
trin mixed with 750 mL of distilled water (Control) or
with an additional 0.3 g  kg−1 body mass of L-glutamine
(Glutamine; Myprotein.co.uk, Manchester, UK). The two
beverages were lemon flavored, masked in an opaque
container, and were indistinguishable in taste and
appearance. Volunteers ingested the same beverage
following the completion of testing at 24, 48, and 72
hours. The glutamine dose of 0.3 g  kg−1 body mass rep-
resented an average daily intake of 26 g  d−1 (≈100 kcal)
for 4 consecutive days post-eccentric exercise. This dose
has previously been demonstrated to acutely elevate
(≈2 hours) plasma glutamine (Ziegler et al. 1990) and is
consistent with doses employed in clinical and exercise
studies without any adverse effects (Wernerman 2008).
Based on the dose-response relationship for oral gluta-
mine, it is reasonable to propose that the dosage would
have acutely elevated plasma glutamine immediately
post-eccentric exercise and at 24-hour intervals for 4 days
following eccentric exercise.
Knee extensor peak torque
Prior to each testing session, volunteers were given
time to stretch and complete a 5-minute warm-up on a
Monark cycle ergometer (Monark Exercise Ab, Vansbro,
Sweden) at 50 revolutions per minute and a resistance
of 1 kp. Maximal voluntary concentric knee extensor
peak torque was determined at angular velocities of
0.52 and 3.14 rad  s−1 using an isokinetic dynamome-
ter with a passive knee flexion return to the start angle
(Biodex 3; Biodex, Shirley, NY, USA). The system was
calibrated for each volunteer prior to each trial accord-
ing to the manufacturer’s instructions. Volunteers pro-
duced five maximal actions at each angular velocity
with a 1-minute recovery separating the two velocities.
The highest peak torque during the five repetitions at
each angular velocity was used as the criterion variable.
Muscle soreness
Muscle soreness was evaluated with a visual analog
scale consisting of a 10-cm horizontal line, utilizing ver-
bal anchors “no soreness” on the left to “maximal sore-
ness” on the right. Volunteers performed an unloaded
squat movement from full knee extension to 90° knee
flexion with return to full knee extension, and were
then asked to place a vertical mark on the horizontal
line on the scale that corresponded to their perception
of muscle soreness. Soreness was quantified by mea-
suring the distance in centimeters from the left hand
end of the scale to the volunteer’s mark.
Plasma CK activity
Plasma CK activity was measured from a 30-μL fingertip
capillary blood sample. Plasma CK activity was ana-
lyzed by spectrophotometry (Jenway, Dunmow, UK) in
accordance with the manufacturer’s guidelines (Randox,
Co. Antrim, UK). The normal resting value of plasma
CK activity is < 200 μL.
Statistical analyses
Data were analyzed with SPSS version 15.0 (SPSS Inc.,
Chicago, IL, USA). Data are presented as mean±standard
deviation unless otherwise stated. Peak torque was
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Table. Physical characteristics of the study participants*
Control group Glutamine group 
(n = 8) (n = 7)
Age (yr) 22.1 ± 3.6 23.3 ± 2.9
Stature (m) 1.86 ± 0.05† 1.78 ± 0.07
Mass (kg) 80.9 ± 9.5 84.9 ± 6.3
*Data presented as mean ± standard deviation; †significantly greater
stature for control group (p = 0.02).
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expressed relative to the pre-exercise peak torque. Peak
torque, soreness, and CK data were analyzed with 
separate two-factor (time×experimental group) repeated
measures ANOVA. Values for plasma CK activity were
transformed to natural log to satisfy the assumptions
of the analysis. An alpha level of p < 0.05 was accepted
as a statistically significant difference between experi-
mental conditions. Follow-up tests on time main effects
were performed using paired sample t-tests applying
the Bonferroni correction procedure, and independent-
sample t-tests were used for group main effects. The
relationship between peak torque and muscle sore-
ness was investigated with the Pearson product
moment correlation coefficient and expressed as the
coefficient of determination (i.e., R2).
Results
Knee extensor peak torque
No differences in concentric peak torque were evident
before eccentric exercise at both 0.52 rad  s−1 (Control,
263 ± 45 N  m; Glutamine, 260 ± 32 N  m, p = 0.90) and
3.14 rad  s−1 (Control, 160 ± 50 N  m; Glutamine, 170 ±
22 N  m, p = 0.64). Figure 1A illustrates that peak torque
at 0.52 rad  s−1, expressed relative to pre-exercise values,
was reduced significantly by 23% at 1 hour (p < 0.001)
and was still significantly reduced by 9% at 96 hours
(p = 0.01). Figure 1B illustrates that peak torque at
3.14 rad  s−1 was reduced significantly by 19% at 1 hour
(p < 0.001) and by 14% at 72 hours (p = 0.005), but
had recovered by 96 hours. Glutamine supplementation
resulted in significantly greater peak torque over the
96-hour measurement period at both 0.52 rad  s−1
(Control, 75 ± 16%; Glutamine, 85 ± 15%, p = 0.03) and
3.14 rad s−1 (Control, 79 ± 16%; Glutamine, 90 ± 12%,
p = 0.01). Glutamine supplementation resulted in signif-
icantly greater peak torque at 48 hours (p = 0.004) and
72 hours (p = 0.009) at 3.14 rad  s−1. Peak torque at
3.14 rad  s−1 had returned to baseline by 72 hours with
glutamine supplementation but was still significantly
reduced at 96 hours (p = 0.008) in the control group.
Muscle soreness
No difference in soreness was evident before eccentric
exercise (Control, 0.4 ± 0.2 cm; Glutamine, 0.5 ± 0.3 cm,
p = 0.35). Figure 2 illustrates that soreness increased
significantly at all time points following eccentric exer-
cise. Glutamine supplementation resulted in significantly
less soreness over the 96-hour testing period (Control,
4.6 ± 2.5 cm; Glutamine, 3.6 ± 2.5 cm, p = 0.03). Glu-
tamine supplementation did not affect the timing or
magnitude of the peak soreness experienced (i.e., at
24 hours: Control, 6.9 ± 0.9 cm; Glutamine, 6.8 ± 0.7 cm,
p=0.70), but diminished soreness more rapidly, resulting
in significantly less soreness at 96 hours (p = 0.001).
Soreness was not associated (p > 0.05) with the magni-
tude of strength loss apart from a weak negative rela-
tionship observed at 1 hour post-exercise (R2 = 0.27,
p = 0.05).
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Fig. 1 Concentric knee-extensor peak torque (expressed as a percent of pre-exercise peak torque) at: (A) 0.52 rad  s−1; 
(B) 3.14 rad  s−1. *Significant difference from baseline for both conditions, p ≤ 0.01; †significant difference between conditions
at time point, p < 0.01.
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Plasma CK activity
Figure 3 shows that plasma CK activity was significantly
elevated above baseline at 1 hour (p = 0.01), 24 hours
(p<0.001), 48 hours (p=0.001), and 72 hours (p=0.005),
reaching peak values at 48 hours. No differences were
apparent between groups for the magnitude and tem-
poral nature of the CK response.
Discussion
The major findings of this study are that oral glutamine
supplementation, immediately post and for 72 hours
after eccentric exercise, resulted in significantly less
strength loss and muscle soreness compared with a
placebo. To our knowledge, this study represents the first
test of the effectiveness of glutamine supplementation as
a therapeutic nutritional supplement in an experimental
model of eccentric exercise-induced muscle damage.
Glutamine supplementation was effective in reduc-
ing muscle damage on the basis of strength measure-
ments. Maximal voluntary contraction provides the most
effective means of evaluating the magnitude and time
course of damage resulting from eccentric exercise
(Warren et al. 1999). Glutamine supplementation re-
duced the average decrement in knee extensor strength
by 10% over 96 hours during both low (25% cf. 15%)
and high (21% cf. 10%) angular velocities of move-
ment. At the high angular velocity, strength returned to
pre-exercise levels by 72 hours with glutamine supple-
mentation but remained significantly reduced in the
control group at 96 hours. Therefore, glutamine supple-
mentation afforded a small but meaningful protection
against strength loss, resulting in a more rapid return to
the pre-damage state at the higher velocity of movement.
Our findings are in agreement with a number of
recent studies reporting positive effects of protein 
or selected amino acid supplementation on muscle
strength following eccentric exercise (Buckley et al.
2010; Etheridge et al. 2008; Nosaka et al. 2006). The
mechanism(s) underlying improved muscle function
in the present and previous studies are not understood.
Our study along with previous studies did not employ
an isoenergetic control and although the additional
energy intake from glutamine was small (≈100kcal  d−1),
it is a potential explanatory factor (Jackman et al. 2010;
Nosaka et al. 2006). Central and peripheral mechanisms
have been demonstrated to contribute to strength loss
(Hubal et al. 2007; Prasartwuth et al. 2005), with peri-
pheral mechanisms accounting for the majority of the
immediate and prolonged loss of strength (Hubal et al.
2007). Suggested peripheral mechanisms of strength
loss include impaired excitation–contraction coupling
(Ingalls et al. 1999), sarcomere length redistribution
(Proske et al. 2001), and leukocyte accumulation (Paulsen
et al. 2010; Raastad et al. 2003; MacIntyre et al. 1996).
A possible mechanism of glutamine action is attenuat-
ing the inflammatory response to eccentric exercise.
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Fig. 2 Muscle soreness on active movement of the knee
extensors. *Significant difference from baseline for both con-
ditions, p < 0.01; †significant difference between conditions
at the time point, p < 0.01.
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Fig. 3 Plasma creatine kinase activity following eccentric
exercise. *Significant difference from baseline for both condi-
tions, p < 0.01.
A local inflammatory response is observed in skele-
tal muscle post-eccentric exercise (Peake et al. 2005),
with the timing and magnitude of leukocyte infiltra-
tion associated with decrements in muscle function
(Paulsen et al. 2010; Raastad et al. 2003; MacIntyre 
et al. 1996). Glutamine is known to maintain protein
balance and plays many cell regulatory and immune
system roles (Roth 2008; Wernerman 2008; Castell
2003; Walsh et al. 1998). Glutamine supplementation
may improve muscle function by attenuating the local
inflammatory response to eccentric exercise (Paulsen
et al. 2010; Raastad et al. 2003; MacIntyre et al. 1996).
Recent animal evidence from rats provides tentative
support for such a hypothesis. Cruzat et al. (2010) re-
ported that glutamine supplementation increased rat
skeletal muscle and plasma glutamine concentrations
and attenuated the inflammatory response to exercise.
In animals supplemented with 1.5 g  kg−1 glutamine
for 21 days, Cruzat et al. (2010) observed higher mus-
cle glutamine concentrations pre- and post-exercise
and lower plasma concentrations of proinflammatory
cytokines (i.e., PGE2 and TNF-α) following 2 hours of
swimming. The authors suggested that myocyte intra-
cellular glutamine transport is accompanied by an
increase in cell water and volume which may increase
resistance to mechanical trauma and subsequent inflam-
matory responses. A basic hypothesis is that glutamine
supplementation maintained glutamine homeostasis
and dependent physiological functions post-eccentric
exercise when glutamine utilization was increased.
Since glutamine is synthesised by branched-chain amino
acid metabolism, it is possible that protein or amino acid
supplementation ensures adequate glutamine synthesis
and release at a time of increased utilization following
eccentric exercise (Parry-Billings et al. 1990).
Glutamine supplementation did not affect the mag-
nitude of muscle soreness experienced but resulted in
a more rapid dissipation of soreness evident as a sig-
nificantly lower soreness at 96 hours. This finding is in
general agreement with two recent studies reporting
positive effects of selected amino acid supplementa-
tion on muscle soreness following eccentric exercise
(Jackman et al. 2010; Nosaka et al. 2006). Nosaka et al.
(2006) reported reduced soreness of the elbow flexors
at 24 and 48 hours post-eccentric exercise when a sup-
plement containing 12 amino acids (3.6 g) including 
L-glutamine was ingested pre, immediately post, and
on eight more occasions over 4 days post-eccentric
exercise. Jackman et al. (2010) observed reduced sore-
ness of the knee extensors at 48 and 72 hours post-
eccentric exercise when a 7.3-g branched-chain amino
acid supplement was ingested four times daily (start-
ing immediately pre-exercise) for 3 days. In contrast to
the present study, both of the aforementioned studies
resulted in a significantly lower peak magnitude of
soreness. Unlike the above studies, our supplementa-
tion regimen did not include a pre-exercise supplement.
Future research may wish to investigate the efficacy 
of an additional pre-exercise glutamine supplement.
Currently, there is no general consensus on the under-
lying mechanisms of muscle soreness following eccen-
tric exercise, although damage and/or inflammation of
the extracellular matrix are a potential etiological factor
(Crameri et al. 2007; Clarkson & Hubal 2002).
The lower muscle soreness with glutamine supple-
mentation could have attenuated strength loss via a
reduction in conscious or reflex inhibition affecting
voluntary activation during maximal voluntary contrac-
tions. Reduced voluntary activation is mainly observed
in the first 24 hours after eccentric exercise (Prasartwuth
et al. 2005) when soreness was comparable between
the glutamine and placebo groups. Glutamine supple-
mentation resulted in significantly lower soreness at
96 hours, whereas strength loss was significantly reduced
at the higher movement velocity at 48 and 72 hours,
and no meaningful associations between soreness and
strength were evident at any time point. Therefore, our
evidence does not suggest that the preservation of
strength was related to the reduced muscle soreness.
In conclusion, our findings provide initial support
for the efficacy of oral glutamine supplementation in
promoting recovery from eccentric exercise-induced
muscle damage. Further research is warranted to inves-
tigate glutamine homeostasis post-eccentric exercise,
the influence of glutamine supplementation on homeo-
stasis, and to confirm the efficacy of oral glutamine
supplementation in improving recovery from exercise-
induced muscle damage. Glutamine supplementation
attenuated the magnitude of strength loss, improved
the time course of strength recovery, and diminished
muscle soreness more rapidly in comparison with an
isocarbohydrate placebo.
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